CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 90 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.5%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$3,410,000
+3.0%
28,796
+2.8%
0.00%0.0%
Q4 2020$3,310,000
+9.7%
28,023
+3.2%
0.00%0.0%
Q3 2020$3,018,000
+5.5%
27,153
-3.0%
0.00%0.0%
Q2 2020$2,862,000
-16.9%
28,005
-12.2%
0.00%
-50.0%
Q1 2020$3,442,000
-12.2%
31,882
-5.4%
0.00%0.0%
Q4 2019$3,922,000
+4.2%
33,694
+2.5%
0.00%0.0%
Q3 2019$3,764,00032,8800.00%
Other shareholders

There were no reported owners of CHINA BIOLOGIC PRODS HLDGS I in Q4 2020.

NameSharesValueWeighting ↓
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders